Mega Lifesciences PCL (BKK: MEGA)

Market Cap	30.73B
Revenue (ttm)	15.88B
Net Income (ttm)	1.85B
Shares Out	871.87M
EPS (ttm)	2.12
PE Ratio	16.66
Forward PE	12.31
Dividend	1.60 (4.54%)
Ex-Dividend Date	n/a

Volume	609,609
Open	35.75
Previous Close	35.50
Day's Range	35.00 - 35.75
52-Week Range	35.00 - 44.25
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2024

About Mega Lifesciences PCL

Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods in Southeast Asia and Sub-Saharan Africa. The company operates in three segments: Brands, Distribution, and Original Equipment Manufacture (OEM). It provides various medicines for allergies; blood circulation and memory; bone and joint; liver and digestive; eyes, heart, and skin; pain, sleeping, well-bei...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1982
• Employees: 900
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: MEGA

Financial Performance

In 2023, Mega Lifesciences PCL's revenue was 15.72 billion, a decrease of -0.07% compared to the previous year's 15.73 billion. Earnings were 1.99 billion, a decrease of -11.10%.